Measuring progression of cerebral white matter lesions on MRI
Niels D. Prins, Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Elisabeth C.W. van Straaten(Amsterdam Neuroscience), Ewoud J. van Dijk(Hermes Arzneimittel (Germany)), Peter J. Koudstaal(Apple (Israel)), Monique M.B. Breteler(University of Bonn), Ronald A. van Schijndel(Amsterdam Neuroscience), Henri A. Vrooman(Erasmus MC), Manuela Simoni(University of Modena and Reggio Emilia), Philip Scheltens(Amsterdam University Medical Centers)
Cited by 179
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k